Bluprynt | $4,250,000 | (Feb 27, 2026)
UpGuard | $75,000,000 | (Feb 27, 2026)
Revel(US) | $150,000,000 | (Feb 27, 2026)
Certified by Founder
Lodge
Baseimmune
start up
United Kingdom
- London, England
- 29/02/2024
- Series A
- $11,402,055
Baseimmune was founded in 2019 as a discovery phase start-up in the antigen discovery and vaccine development field.
- Industry Biotechnology Research
- Website https://www.baseimmune.co.uk/
- LinkedIn https://www.linkedin.com/company/baseimmune/
Related People
Joshua BlightCo Founder
United Kingdom -
ND
Research scientist and biotech co-founder specialising in infectious diseases with a particular interest in mosquito-borne diseases. Skilled in Bioinformatics, Cell Biology, Vaccinology, Immunology, Parasitology and Molecular Biology. Additional experience in Science Communication, Public Engagement and Graphic Design. DPhil in Clinical Medicine, Oxford.
![[cafeteria]](/uploads/YMFDSSydz53lMbT1730171990.png)
Alpa | $3,500,000 | (Feb 27, 2026)
ElastixAI | $18,000,000 | (Feb 27, 2026)
Callosum | $10,250,000 | (Feb 27, 2026)
JetScale AI | $5,400,000 | (Feb 27, 2026)
Dots | $8,900,000 | (Feb 27, 2026)
VITURE | $100,000,000 | (Feb 27, 2026)
Jest | $7,000,000 | (Feb 27, 2026)
Sinergy Flow | $8,273,230 | (Feb 26, 2026)